SCHEMBL7909596

SCHEMBL7909596

CC(=NOC(=O)c1ccccc1)N(CCCC[C@H](N)C(=O)O)OC(=O)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.40
CDK5 Q00535 2/20 0.40
CDK5R1 Q15078 2/20 0.40
PKM P14618 2/20 0.40
NOS2 P35228 5/20 0.39
NOS1 P29475 4/20 0.39
NOS3 P29474 3/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
TSHR P16473 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
BLM P54132 1/20 0.38
NPC1 O15118 4/20 0.38
RAB9A P51151 4/20 0.38
KMT2A Q03164 2/20 0.38
POLB P06746 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
RBBP9 O75884 1/20 0.37
TNF P01375 1/20 0.37
KLF5 Q13887 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7909588 1.00 MAPT (0.40) MAPTCDK5CDK5R1PKMNOS2
SCHEMBL7901737 0.84 NOS1 (0.41) PKMNOS2NOS1NOS3CYP1A2
SCHEMBL7225445 0.78 NOS2 (0.46) NOS2NOS1NOS3CYP1A2CYP3A4
SCHEMBL7225440 0.78 NOS2 (0.46) NOS2NOS1NOS3CYP1A2CYP3A4
Hydrochloric Acid SCHEMBL8202178 0.77 NOS2 (0.47) NOS2NOS1NOS3CYP1A2CYP3A4
Hydrochloric Acid SCHEMBL8202182 0.77 NOS2 (0.47) NOS2NOS1NOS3CYP1A2CYP3A4
SCHEMBL7909659 0.76 NOS2 (0.43) NOS2NOS1NOS3CYP1A2CYP3A4
SCHEMBL8200560 0.76 NOS2 (0.43) NOS2NOS1NOS3CYP1A2CYP3A4
SCHEMBL7225511 0.76 TNF (0.41) MAPTCDK5CDK5R1PKMNOS2
SCHEMBL7908800 0.76 TNF (0.41) MAPTCDK5CDK5R1PKMNOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6207708-B1 FOR THERAPY AND PROPHYLAXIS OF AUTOIMMUNE AND/OR INFLAMMATORY CONDITIONS AFFECTING THE JOINTS SUCH AS ARTHRITIS, AND INFLAMMATORY BOWEL DISEASE, CARDIVASCULAR ISCHEMIA, DIABETES, CONGESTIVE HEART FAILURE, MYOCARDITIS, ATHEROSCLEROSIS, G. D. SEARLE & COMPANY 2001-03-27 US claimed
EP-0885188-B1 HYDROXYAMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS SEARLE & CO (US) 2000-09-27 EP claimed
EP-0885188-A1 HYDROXYAMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS G.D. SEARLE & CO. (US) 1998-12-23 EP claimed
WO-1997032844-A1 HYDROXYAMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS G.D. SEARLE & CO. (US) 1997-09-12 WO claimed